Annual Shareholders Equity
$36.38 M
-$30.10 M-45.28%
31 December 2023
Summary:
Actinium Pharmaceuticals annual stockholders equity is currently $36.38 million, with the most recent change of -$30.10 million (-45.28%) on 31 December 2023. During the last 3 years, it has fallen by -$37.17 million (-50.54%). ATNM annual shareholders equity is now -50.54% below its all-time high of $73.55 million, reached on 31 December 2021.ATNM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$38.21 M
-$5.63 M-12.84%
30 September 2024
Summary:
Actinium Pharmaceuticals quarterly stockholders equity is currently $38.21 million, with the most recent change of -$5.63 million (-12.84%) on 30 September 2024. Over the past year, it has increased by +$1.83 million (+5.03%). ATNM quarterly shareholders equity is now -52.54% below its all-time high of $80.50 million, reached on 30 June 2021.ATNM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATNM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +5.0% |
| 3 y3 years | -50.5% | -48.0% |
| 5 y5 years | +544.6% | +577.0% |
ATNM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.5% | at low | -51.1% | +5.0% |
| 5 y | 5 years | -50.5% | +544.6% | -52.5% | +1165.2% |
| alltime | all time | -50.5% | +1992.3% | -52.5% | +383.7% |
Actinium Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.21 M(-12.8%) |
| June 2024 | - | $43.84 M(-0.1%) |
| Mar 2024 | - | $43.86 M(+20.6%) |
| Dec 2023 | $36.38 M(-45.3%) | $36.38 M(-16.5%) |
| Sept 2023 | - | $43.58 M(-17.9%) |
| June 2023 | - | $53.08 M(-7.2%) |
| Mar 2023 | - | $57.21 M(-13.9%) |
| Dec 2022 | $66.48 M(-9.6%) | $66.48 M(-6.7%) |
| Sept 2022 | - | $71.25 M(-8.9%) |
| June 2022 | - | $78.18 M(+13.6%) |
| Mar 2022 | - | $68.84 M(-6.4%) |
| Dec 2021 | $73.55 M(+19.9%) | $73.55 M(-8.4%) |
| Sept 2021 | - | $80.28 M(-0.3%) |
| June 2021 | - | $80.50 M(+13.8%) |
| Mar 2021 | - | $70.74 M(+15.4%) |
| Dec 2020 | $61.32 M(+986.4%) | $61.32 M(+35.0%) |
| Sept 2020 | - | $45.43 M(-10.5%) |
| June 2020 | - | $50.77 M(+1581.3%) |
| Mar 2020 | - | $3.02 M(-46.5%) |
| Dec 2019 | $5.64 M(-36.0%) | $5.64 M(-43.2%) |
| Sept 2019 | - | $9.94 M(-36.7%) |
| June 2019 | - | $15.70 M(+193.9%) |
| Mar 2019 | - | $5.34 M(-39.4%) |
| Dec 2018 | $8.81 M(-35.5%) | $8.81 M(-23.9%) |
| Sept 2018 | - | $11.58 M(-33.1%) |
| June 2018 | - | $17.32 M(-20.4%) |
| Mar 2018 | - | $21.75 M(+59.1%) |
| Dec 2017 | $13.67 M(-24.1%) | $13.67 M(-24.9%) |
| Sept 2017 | - | $18.19 M(+105.1%) |
| June 2017 | - | $8.87 M(-31.1%) |
| Mar 2017 | - | $12.88 M(-28.5%) |
| Dec 2016 | $18.01 M(-18.0%) | $18.01 M(+26.5%) |
| Sept 2016 | - | $14.23 M(-25.4%) |
| June 2016 | - | $19.08 M(-4.9%) |
| Mar 2016 | - | $20.06 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $21.97 M(-1243.0%) | $21.97 M(-4.0%) |
| Sept 2015 | - | $22.89 M(-1.7%) |
| June 2015 | - | $23.28 M(+41.6%) |
| Mar 2015 | - | $16.44 M(-955.4%) |
| Dec 2014 | -$1.92 M(+23.3%) | -$1.92 M(-181.1%) |
| Sept 2014 | - | $2.37 M(-45.2%) |
| June 2014 | - | $4.33 M(-132.2%) |
| Mar 2014 | - | -$13.47 M(+763.6%) |
| Dec 2013 | -$1.56 M(-236.1%) | -$1.56 M(-358.1%) |
| Sept 2013 | - | $604.30 K(-68.4%) |
| June 2013 | - | $1.91 M(+247.7%) |
| Mar 2013 | - | $550.80 K(-51.9%) |
| Dec 2012 | $1.15 M(+15.5%) | $1.15 M(-1201.5%) |
| Sept 2012 | - | -$104.00 K(+3.7%) |
| June 2012 | - | -$100.30 K(+6.7%) |
| Mar 2012 | - | -$94.00 K(-109.5%) |
| Dec 2011 | $992.00 K(-1148.6%) | $992.00 K(-1314.2%) |
| Sept 2011 | - | -$81.70 K(+4.5%) |
| June 2011 | - | -$78.20 K(-20.7%) |
| Mar 2011 | - | -$98.60 K(+4.2%) |
| Dec 2010 | -$94.60 K(-1.8%) | -$94.60 K(+9.9%) |
| Sept 2010 | - | -$86.10 K(+12.7%) |
| June 2010 | - | -$76.40 K(-27.0%) |
| Mar 2010 | - | -$104.60 K(+8.6%) |
| Dec 2009 | -$96.30 K(+30.1%) | -$96.30 K(+10.9%) |
| Sept 2009 | - | -$86.80 K(+4.7%) |
| June 2009 | - | -$82.90 K(+4.5%) |
| Mar 2009 | - | -$79.30 K(+7.2%) |
| Dec 2008 | -$74.00 K(+73.3%) | -$74.00 K(+11.6%) |
| Sept 2008 | - | -$66.30 K(+5.2%) |
| June 2008 | - | -$63.00 K(+17.8%) |
| Mar 2008 | - | -$53.50 K(+25.3%) |
| Dec 2007 | -$42.70 K(+132.1%) | -$42.70 K(+49.3%) |
| Sept 2007 | - | -$28.60 K(+28.8%) |
| June 2007 | - | -$22.20 K(+20.7%) |
| Dec 2006 | -$18.40 K | -$18.40 K |
FAQ
- What is Actinium Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Actinium Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ATNM is $36.38 M
What is the all time high annual shareholders equity for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual stockholders equity is $73.55 M
What is Actinium Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ATNM is $38.21 M
What is the all time high quarterly shareholders equity for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly stockholders equity is $80.50 M
What is Actinium Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ATNM quarterly stockholders equity has changed by +$1.83 M (+5.03%)